D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 78 Citations 19,902 395 World Ranking 10777 National Ranking 5768

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Surgery

His main research concerns Prostate cancer, Prostate, Pathology, Cancer and Internal medicine. He does research in Prostate cancer, focusing on Prostate-specific antigen specifically. His work carried out in the field of Prostate brings together such families of science as Surgery, Biopsy, Radiology and Contrast.

His Pathology research incorporates elements of Bladder cancer, Epithelial cell adhesion molecule, Tumor marker and Circulating tumor cell. He has researched Cancer in several fields, including Progressive disease, Cancer research, Logistic regression and Paxillin. His Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology and Oncology.

His most cited work include:

  • Effect of dutasteride on the risk of prostate cancer. (830 citations)
  • Micro-RNA profiling in kidney and bladder cancers (518 citations)
  • MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. (401 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Prostate cancer, Internal medicine, Oncology, Surgery and Prostate. His biological study spans a wide range of topics, including Radiation therapy and Urology. His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology and Gynecology.

The various areas that Leonard G. Gomella examines in his Surgery study include Nephrectomy and Radical retropubic prostatectomy. His work in Prostate covers topics such as Biopsy which are related to areas like Prostate biopsy. The study incorporates disciplines such as Cancer research and Pathology in addition to Cancer.

He most often published in these fields:

  • Prostate cancer (45.54%)
  • Internal medicine (32.67%)
  • Oncology (26.24%)

What were the highlights of his more recent work (between 2017-2021)?

  • Prostate cancer (45.54%)
  • Internal medicine (32.67%)
  • Oncology (26.24%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Prostate cancer, Internal medicine, Oncology, Prostate and Prostatectomy. The subject of his Prostate cancer research is within the realm of Cancer. Leonard G. Gomella interconnects Germline mutation and Antibiotic prophylaxis in the investigation of issues within Internal medicine.

The study incorporates disciplines such as Genetic testing, Androgen deprivation therapy, Radiation therapy and Germline in addition to Oncology. His Prostatectomy study also includes

  • Clinical scenario most often made with reference to Nomogram,
  • Radiology which intersects with area such as Median follow-up. The various areas that Leonard G. Gomella examines in his Cancer research study include Prostate-specific antigen, Messenger RNA and Transcription factor, GATA2.

Between 2017 and 2021, his most popular works were:

  • Short Term Androgen Deprivation Therapy Without or With Pelvic Lymph Node Treatment Added to Prostate Bed Only Salvage Radiotherapy: The NRG Oncology/RTOG 0534 SPPORT Trial (74 citations)
  • Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial (48 citations)
  • Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import (44 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Surgery

Prostate cancer, Internal medicine, Oncology, Cancer research and Prostate are his primary areas of study. Prostate cancer is a subfield of Cancer that Leonard G. Gomella explores. His Cohort and Male patient study in the realm of Internal medicine interacts with subjects such as Rucaparib, Olaparib and Periprosthetic.

His Oncology study integrates concerns from other disciplines, such as Precision medicine, Germline mutation, Germline, Androgen deprivation therapy and Genetic testing. While the research belongs to areas of Cancer research, Leonard G. Gomella spends his time largely on the problem of Transcription factor, intersecting his research to questions surrounding Genetic screen, Prostate-specific antigen and Messenger RNA. His Prostate research integrates issues from Urinary system, Median follow-up, Brachytherapy and Toxicity.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Effect of dutasteride on the risk of prostate cancer.

Gerald L. Andriole;David G. Bostwick;Otis W. Brawley;Leonard G. Gomella.
The New England Journal of Medicine (2010)

1172 Citations

Micro-RNA profiling in kidney and bladder cancers

Fedra Gottardo;Fedra Gottardo;Chang Gong Liu;Manuela Ferracin;George A. Calin.
Urologic Oncology-seminars and Original Investigations (2007)

739 Citations

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets.

Raffaele Baffa;Matteo Fassan;Matteo Fassan;Stefano Volinia;Brian O'Hara.
The Journal of Pathology (2009)

581 Citations

Detection of hematogenous micrometastasis in patients with prostate cancer

J G Moreno;C M Croce;R Fischer;M Monne.
Cancer Research (1992)

487 Citations

Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- And tissue-specific microRNAs

Eric Londina;Phillipe Lohera;Aristeidis G. Telonis;Kevin Quann.
Proceedings of the National Academy of Sciences of the United States of America (2015)

421 Citations

A Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Carcinoma In Situ in Patients With Bladder Cancer: A Phase III, Multicenter Study

Yves Fradet;H. Barton Grossman;Leonard Gomella;Seth Lerner.
The Journal of Urology (2007)

355 Citations

Utilization of polymerase chain reaction technology in the detection of solid tumors

Ganesh V. Raj M.D.;Jose G. Moreno;Leonard G. Gomella.
Cancer (1998)

344 Citations

A Phase III, Multicenter Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Superficial Papillary Lesions in Patients With Bladder Cancer

H. Barton Grossman;Leonard Gomella;Yves Fradet;Alvaro Morales.
The Journal of Urology (2007)

343 Citations

CHEMOPREVENTION OF PROSTATE CANCER IN MEN AT HIGH RISK: RATIONALE AND DESIGN OF THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL

Gerald Andriole;David Bostwick;Otis Brawley;Leonard Gomella.
The Journal of Urology (2004)

342 Citations

Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer.

Gary R. Hudes;Faith Nathan;Christina Khater;Naomi Haas.
Journal of Clinical Oncology (1997)

329 Citations

Editorial Boards

Canadian Journal of Urology
(Impact Factor: 1.683)

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Leonard G. Gomella

Stephen J. Freedland

Stephen J. Freedland

Cedars-Sinai Medical Center

Publications: 142

Gerald L. Andriole

Gerald L. Andriole

Washington University in St. Louis

Publications: 89

Eric A. Klein

Eric A. Klein

Cleveland Clinic

Publications: 58

Shahrokh F. Shariat

Shahrokh F. Shariat

Medical University of Vienna

Publications: 57

Ian M. Thompson

Ian M. Thompson

The University of Texas Health Science Center at San Antonio

Publications: 55

Renato V. Iozzo

Renato V. Iozzo

Thomas Jefferson University

Publications: 52

Carlo M. Croce

Carlo M. Croce

The Ohio State University

Publications: 51

Francesco Montorsi

Francesco Montorsi

Vita-Salute San Raffaele University

Publications: 48

R. Jeffrey Karnes

R. Jeffrey Karnes

Mayo Clinic

Publications: 44

Peter R. Carroll

Peter R. Carroll

University of California, San Francisco

Publications: 43

Paul L. Nguyen

Paul L. Nguyen

Brigham and Women's Hospital

Publications: 41

Adam P. Dicker

Adam P. Dicker

Thomas Jefferson University

Publications: 41

Neil Fleshner

Neil Fleshner

Princess Margaret Cancer Centre

Publications: 40

Claus G. Roehrborn

Claus G. Roehrborn

The University of Texas Southwestern Medical Center

Publications: 40

Jianfeng Xu

Jianfeng Xu

NorthShore University HealthSystem

Publications: 38

Philip W. Kantoff

Philip W. Kantoff

Memorial Sloan Kettering Cancer Center

Publications: 37

Trending Scientists

Dzung L. Pham

Dzung L. Pham

Henry M. Jackson Foundation

Ruggero Caminiti

Ruggero Caminiti

Sapienza University of Rome

Marc T. M. Koper

Marc T. M. Koper

Leiden University

Wenjun Wu

Wenjun Wu

East China University of Science and Technology

Davide Barreca

Davide Barreca

University of Padua

Gad Shaulsky

Gad Shaulsky

Baylor College of Medicine

Randall S. Wells

Randall S. Wells

Chicago Zoological Society

Sai Kiang Lim

Sai Kiang Lim

Agency for Science, Technology and Research

Antonio Figueras

Antonio Figueras

Spanish National Research Council

Claudia Ringler

Claudia Ringler

International Food Policy Research Institute

Carsten Wrosch

Carsten Wrosch

Concordia University

Jerome L. Singer

Jerome L. Singer

Yale University

Brandon A. Gaudiano

Brandon A. Gaudiano

Brown University

Bert Hayslip

Bert Hayslip

University of North Texas

Timothy C. Fabian

Timothy C. Fabian

University of Tennessee Health Science Center

Something went wrong. Please try again later.